
Please try another search
Major U.S. benchmarks registered the biggest decline in around a month following disappointing third-quarter results from Alcoa (NYSE:AA). A strengthening U.S. dollar, which was boosted by rising speculations of a rate hike in December, also weighed on markets. Moreover, a drop in oil prices had a negative impact on investor sentiment. Among the top ETFs, investors saw (AX:SPY) gain nearly 1.3%, while (V:DIA) decreased nearly 1.1% and QQQ fell about 1.4% on the day.
Two more specialized ETFs are worth noting in particular though as both saw trading volume that was far outside of normal. In fact, in the most recent trading session, both these funds experienced volume levels that were more than double their average. This could make these ETFs the ones to watch out for in the days ahead to see if this trend of extra interest continues:
(HN:PXI) : Volume 3.90 times average
This energy momentum ETF tracking the DWA Energy Technical Leaders Index was in focus yesterday as roughly 54,190 shares moved hands compared with an average of roughly 14,590 shares. PXI declined over 0.9% on the day.
Oil prices declined on Tuesday after the International Energy Agency reported that the Organization of the Petroleum Exporting Countries boosted crude production by 160,000 barrels per day to hit a record high level of 33.64 million barrels per day last month. This was one of the main reasons behind the energy ETF’s decline. However, in the last one-month period, PXI was up 4.2%. The fund has a Zacks ETF Rank #5 (Strong Sell).
(AX:BIS) : Volume 3.10 times average
This inverse biotech ETF was under the microscope on Tuesday as nearly 1.07 million shares moved hands. This compares to an average trading volume of 360,510 shares and came as BIS surged 7.4% in the session.
The iShares Nasdaq Biotechnology dropped 3.8%, witnessing the worst one-day performance since the Brexit referendum, on 24.8% plunge in shares of Illumina (NASDAQ:ILMN), which reduced its outlook for third-quarter revenues. Moreover, increasing chances of Hillary Clinton’s win in the upcoming Presidential election weighed on the sector. BIS that seeks to follow the inverse of biotech sector’s performance gained from this scenario. Also, in the last one-month period, BIS was up nearly 5.8%.
Want key ETF info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>
Tesla (NASDAQ:TSLA) (NYSE: TSLA), the electric vehicle giant, has recently experienced a significant drop in its stock value, which has fallen nearly 45% since December. This...
Professional traders get paid because of one skill and one skill only: the ability to foresee what the world (or the economy, at least) might look like in six to nine months....
Oracle (NYSE:ORCL) reports after the closing bell Monday, March 10th, 2025, with street consensus expecting $1.49 in earnings per share on $14.39 billion in revenue, for expected...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.